AbbVies Atogepant Meets Goal in Late-Stage Menstrual Migraine Study
ABBVs atogepant delivers positive LUNA data in menstrual migraine, potentially expanding its migraine franchise and addressing an unmet need.…
256,010$
0,40%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
AbbVies diversified portfolio faces patent headwinds, while Novo Nordisk dominates a faster-growing market, but one trades at a steeper valuation.…
AbbVies Immunology Franchise: From Skyrizi & Rinvoq to Whats Next
ABBVs Skyrizi and Rinvoq drives immunology growth, while new indications, acquisitions and partnerships build its next wave.…
ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie
…
ROUNDUP: Botox und Co. - Minimalinvasive Eingriffe immer gefragter
BERLIN (dpa-AFX) - Immer mehr Menschen lassen minimalinvasive Eingriffe beim Schönheitschirurgen durchführen. Zu minimalinvasiven Eingriffen gehören…